Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Introducing errors in short-lived RNA causes tumors to present antigens on their cell surface, stimulating an immune response.
Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.
Tecentriq after surgery and chemotherapy delayed recurrence in people with Stage II or III non-small-cell lung cancer.
In a lab study, brief disruptions of gene machinery make tumor cells more “visible” to immune system.
Some people with blood cancers, however, may not be as well protected.
Encouraging clinical trials find new immunotherapy drugs targeting a certain protein may be effective treatments for melanoma.
A combination of two immunotherapy drugs may be more effective than the current standard treatment, chemotherapy.
People diagnosed with advanced melanoma may soon have a new treatment option that combines two immunotherapy drugs.
More people treated with Opdivo plus Yervoy reached the 6.5-year survival mark than those treated with either drug alone.
Michael Whitley, 43, has a can-do attitude that helps him navigate a complex path through metastatic kidney cancer.
Several new medications for kidney cancer have been approved in recent years.
Alexandra-Chloé Villani, PhD, and her team tackle a perplexing issue—the adverse side effects of immunotherapy drugs.
It’s well known that some viruses can cause cancer—but others are cancer killers.
In patients at high risk of relapse, adjuvant therapy with Keytruda prolonged disease-free survival.
The five scientists with exceptional promise and novel approaches to fighting cancer have been named the 2021 recipients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.